These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15917553)

  • 21. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone resistance in Haemophilus influenzae from nursing home residents in Taiwan: correlation of MICs and mutations in QRDRs.
    Chang CM; Shih HI; Wu CJ; Lauderdale TL; Lee NY; Lee CC; Chen YC; Huang CC; Ko WC
    J Appl Microbiol; 2020 Jun; 128(6):1624-1633. PubMed ID: 31951091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P; Torres MJ; Aznar J
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):180-3. PubMed ID: 22365183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan.
    Ko WC; Yan JJ; Lee NY; Wu HM; Wu JJ
    Microb Drug Resist; 2004; 10(4):306-12. PubMed ID: 15650375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.
    Yan SS; Schreckenberger PC; Zheng X; Nelson NA; Harrington SM; Tjhio J; Fedorko DP
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):205-9. PubMed ID: 18554840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.
    de la Campa AG; Balsalobre L; Ardanuy C; Fenoll A; Pérez-Trallero E; Liñares J;
    Emerg Infect Dis; 2004 Oct; 10(10):1751-9. PubMed ID: 15504260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.
    Powis J; McGeer A; Duncan C; Goren R; de Azavedo JC; Bast DJ; Pong-Porter S; Mazzulli T; Green K; Willey B; Low DE
    Antimicrob Agents Chemother; 2005 May; 49(5):2130-2. PubMed ID: 15855546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.
    Tazi A; Gueudet T; Varon E; Gilly L; Trieu-Cuot P; Poyart C
    Emerg Infect Dis; 2008 Feb; 14(2):349-50. PubMed ID: 18258143
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular epidemiology of Streptococcus agalactiae recovered from significant bacteriuria.
    Schuab RB; Arêas GP; Souza VC; Barros RR
    Infect Dis (Lond); 2015 Sep; 47(9):637-42. PubMed ID: 25901729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
    Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
    J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE; Wagner J; Arvand M
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
    Canton R; Morosini M; Enright MC; Morrissey I
    J Antimicrob Chemother; 2003 Dec; 52(6):944-52. PubMed ID: 14585861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K; Hirakata Y; Yano H; Kanamori H; Endo S; Hirotani A; Abe Y; Nagasawa M; Kitagawa M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Takayama Y; Yamamoto N; Kunishima H; Kaku M
    J Antimicrob Chemother; 2011 Mar; 66(3):494-8. PubMed ID: 21172783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
    Murayama SY; Seki C; Sakata H; Sunaoshi K; Nakayama E; Iwata S; Sunakawa K; Ubukata K;
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2650-3. PubMed ID: 19332682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA gyrase and topoisomerase IV mutations in an in vitro fluoroquinolone-resistant Coxiella burnetii strain.
    Vranakis I; Sandalakis V; Chochlakis D; Tselentis Y; Psaroulaki A
    Microb Drug Resist; 2010 Jun; 16(2):111-7. PubMed ID: 20438350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital.
    Ryu H; Park YJ; Kim YK; Chang J; Yu JK
    J Infect Chemother; 2014 Aug; 20(8):509-11. PubMed ID: 24880684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro.
    Hansen H; Heisig P
    Microb Drug Resist; 2003; 9(1):25-32. PubMed ID: 12705680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of fluoroquinolone resistance.
    Chen FJ; Lo HJ
    J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.